The Physician Payments Sunshine Act requires public reporting of interactions between physicians and biopharmaceutical and medical technology (medtech) professionals through a new public database. Biopharmaceutical and medtech companies began collecting data on these interactions starting in August of 2013. The initial “Open Payments” database was made available to the public on September 30, 2014. Companies will continue to provide new data each year for inclusion in the database.
With proper context, this database will help patients understand how their physicians work with biopharmaceutical and medtech professionals. Partners for Healthy Dialogues was created to provide details about these interactions and help the public understand why they are essential to lifesaving medical breakthroughs, the safe and effective use of medical technologies, the development of new medicines and technologies, and improvements in the care we all receive.
When it comes to our health, collaboration between physicians and biopharmaceutical professionals is essential to improving the care we receive and developing new treatments and diagnostics. Whether it’s collaborating on research for new medicines or technologies, or learning about the latest treatment options or tests, interactions between physicians and biopharmaceutical and medtech professionals lead to better health and better medicine.
Learn more about the value of interactions between physicians and biopharmaceutical and medtech professionals and how these collaborations impact our health and medical progress.